McNaughton, A., Paton, R., Edmans, M., Youngs, J., Wellens, J., Phalora, P., Fyfe, A., Belij-Rammerstorfer, S., Bolton, J., Ball, J., Carnell, G., Dejnirattisai, W., Dold, C., Eyre, D., Hopkins, P., Howarth, A., Kooblall, K., Klim, H., Leaver, S., Lee, L., López-Camacho, C., Lumley, S., Macallan, D., Mentzer, A., Provine, N., Ratcliff, J., Slon-Compos, J., Skelly, D., Stolle, L., Supasa, P., Temperton, N., Walker, C., Wang, B., Wyncoll, D., Simmonds, P., Lambe, T., Baillie, J., Semple, M., Openshaw, P., Obolski, U., Turner, M., Carroll, M., Mongkolsapaya, J., Screaton, G., Kennedy, S., Jarvis, L., Barnes, E., Dunachie, S., Lourenço, J., Matthews, P., Bicanic, T., Klenerman, P., Gupta, S. & Thompson, C. 2022, 'Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses', JCI Insight, 7(13), article no: e156372. https://doi.org/10.1172/jci.insight.156372